Why is Brooks Lab. falling/rising?

As of 14-Jul, Brooks Laboratories Ltd is experiencing a price increase, currently at 151.00, which reflects a rise of 2.95 or 1.99%. The stock has shown strong performance recently, gaining 8.17% over the past four days and outperforming its sector by 1.09% today. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating positive momentum. The stock's performance over the past week has been particularly notable, with a return of 7.66%, significantly outpacing the Sensex, which has declined by 1.42%. However, despite these short-term gains, the company has weak long-term fundamentals, including a return on equity of 0% and declining net sales over the past five years.
In the broader market context, Brooks Laboratories Ltd has outperformed the benchmark indices in both the short and long term, generating a 21.14% return over the past month compared to the Sensex's 1.40%. While the stock has shown impressive returns of 74.65% over the past year and 81.49% over the past three years, concerns about its long-term growth potential and high valuation metrics persist. The company's ability to service its debt is also in question, which may affect investor sentiment despite the recent price rise.